Previous Section
Clinical Trials
31. Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
- Author
- Oran B; Giralt S; Saliba R; Hosing C; Popat U; Khouri I; Couriel D; Qazilbash M; Anderlini P; Kebriaei P; Ghosh S; Carrasco-Yalan A; de Meis E; Anagnostopoulos A; Donato M; Champlin RE; de Lima M; Oran B; Giralt S; Saliba R; Hosing C; Popat U; Khouri I; Couriel D; Qazilbash M; Anderlini P; Kebriaei P; Ghosh S; Carrasco-Yalan A; de Meis E; Anagnostopoulos A; Donato M; Champlin RE; de Lima M;
- Institution
- M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
- Journal
- Biol Blood Marrow Transplant. 2007 Apr;13(4):454-62. Epub 2007 Feb 8.
- Abstract URL
- Click here to view abstract
32. Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib.
- Author
- Heidel F; Cortes J; Rucker FG; Aulitzky W; Letvak L; Kindler T; Huber C; Dohner H; Kantarjian H; Fischer T; Heidel F; Cortes J; Rucker FG; Aulitzky W; Letvak L; Kindler T; Huber C; Dohner H; Kantarjian H; Fischer T;
- Institution
- Department Internal Medicine III, University-Hospital, Mainz, Germany.
- Journal
- Cancer. 2007 Mar 1;109(5):907-14.
- Abstract URL
- Click here to view abstract
33. The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.
- Author
- Ito Y; Ohyashiki K; Yoshida I; Takeuchi M; Aoyama Y; Mugitani A; Matsuura Y; Wakita H; Matsuda M; Sakamoto E; Kiguchi T; Urabe A; Tamura K; Kanamaru A; Masaoka T; Ito Y; Ohyashiki K; Yoshida I; Takeuchi M; Aoyama Y; Mugitani A; Matsuura Y; Wakita H; Matsuda M; Sakamoto E; Kiguchi T; Urabe A; Tamura K; Kanamaru A; Masaoka T;
- Institution
- First Department of Internal Medicine (Hematology Division), Tokyo Medical University, Tokyo, Japan. yito@tokyo-med.ac.jp
- Journal
- Int J Hematol. 2007 Feb;85(2):121-7.
- Abstract URL
- Click here to view abstract
34. A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.
- Author
- Horton TM; Pati D; Plon SE; Thompson PA; Bomgaars LR; Adamson PC; Ingle AM; Wright J; Brockman AH; Paton M; Blaney SM;
- Institution
- Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA. tmhorton@txccc.org
- Journal
- Clin Cancer Res. 2007 Mar 1;13(5):1516-22.
- Abstract URL
- Click here to view abstract
